Good fetal outcome following prolonged indomethacin induced anhydramnios. Case report.
Indomethacin is a non steroidal anti-inflammatory agent widely employed in the treatment of premature contractions. Indomethycin induced oligohydramnios is a well described side-effect, and is considered an indication for treatment discontinuation. We present a case of prolonged anhydramnios, secondary to indomethacin therapy with no apparent ill-effect on the fetus or neonate.
Shen
O
O
Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Jerusalem, Israel.
Rabinowitz
R
R
Lavie
O
O
Aboulafia
Y
Y
Diamant
Y Z
YZ
D000328:Adult; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects* / Q000627:therapeutic use; D007231:Infant, Newborn; D007752:Obstetric Labor, Premature / Q000517:prevention & control; D016104:Oligohydramnios / Q000139:chemically induced* / Q000175:diagnosis; D011247:Pregnancy; D011256:Pregnancy Outcome; D015149:Tocolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use
D015149:Tocolytic Agents; D007213:Indomethacin